Maxim Group Downgrades Amryt Pharma to Hold

Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.

Maxim Group analyst Jason McCarthy downgrades Amryt Pharma (NASDAQ:AMYT) from Buy to Hold.

Total
0
Shares
Related Posts